{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-030651","form_type":"8-K","ticker":"EDSA","cik":"0001540159","company_name":"Edesa Biotech, Inc.","filed_at":"2022-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.923593+00:00","generated_at":"2026-06-27T01:34:19.296303+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Edesa Biotech amends equity distribution agreement with RBC for up to $15.4M ATM","bullets":["Amended Equity Distribution Agreement with RBC Capital Markets to sell up to $15.4M additional common shares.","Previously sold 487,228 shares for $2.5M under the prior agreement.","Amendment enables ongoing at-the-market offerings through RBC as sales agent or principal.","Legal opinion from Fasken Martineau DuMoulin LLP regarding share legality attached as exhibit."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-030651","json":"https://secwatch.observer/filing/0001104659-22-030651.json","markdown":"https://secwatch.observer/filing/0001104659-22-030651.md","text":"https://secwatch.observer/filing/0001104659-22-030651.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1540159/000110465922030651/0001104659-22-030651-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1540159/000110465922030651/tm228418d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T01:34:19.296303+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}